Caicedo-Herrera Gabriela, Candelo Estephania, Pachajoa Harry
Centro de Investigaciones en Anomalías Congénitas y Enfermedades Raras, Universidad ICESI, Cali, Colombia.
Fundación Clínica Valle De Lili, Cali, Colombia.
Arch Argent Pediatr. 2017 Oct 1;115(5):e287-e290. doi: 10.5546/aap.2017.e287.
Tuberous sclerosis complex (TSC) is a neurocutaneous autosomal dominant disorder that results from mutations within either the TSC1 gene or the TSC2 gene. Diagnosis is based on well-established clinical criteria or genetic criteria. Clinical features are highly variable and could be developing over the life. We present a case of TSC with a molecular test that identified a novel variant in TSC2 gene. It is a sporadic missense mutation which has not been previously reported in the literature. It is caused by premature termination of protein translation and results in the production of truncated and non-functional proteins. This mutation is considered as a pathogenic variant and allows to broaden the spectrum of variants of TSC2 gene as a cause of TSC.